🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery

RecruitingNAAges 18 Years - 65 YearsFemaleNational Cancer Institute, Egypt
NCT05361837 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients scheduled for modified radical mastectomy, * Age 18-65 years, * ASA I-II Exclusion Criteria: * patient refusal, * coagulation defects, * abnormal kidney or liver functions, * local infection at site of injection.
💊

What it tests

  • Single level serratus anterior plane block
  • Single level serratus anterior plane block with dexmedetomidine
  • Bilevel serratus anterior plane block
  • Bilevel serratus anterior plane block with dexmedetomidine
📍

Where

1 site
Walaa Y Elsabeeny
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy